Most thyroid nodules don’t need treatment at all. Roughly 95% or more are benign, and many are simply monitored with periodic ultrasounds. When treatment is necessary, the approach depends on whether the nodule is causing symptoms, producing excess thyroid hormone, or showing signs of cancer. Options range from watchful waiting to radiofrequency ablation to surgery.
How Doctors Decide What a Nodule Needs
The first step is figuring out whether a nodule is suspicious enough to biopsy. Doctors use an ultrasound-based scoring system called TIRADS that rates nodules from low to high risk based on their shape, margins, brightness, and whether they contain tiny calcium deposits called microcalcifications. The higher the suspicion score, the smaller a nodule needs to be before a needle biopsy is recommended.
Under the European Thyroid Association’s 2023 guidelines, the thresholds work like this: high-suspicion nodules (those with irregular shapes, irregular margins, or microcalcifications) get biopsied once they reach 10 mm. Intermediate-suspicion nodules are biopsied at 15 mm, and low-suspicion nodules at 20 mm. If a nodule of any size sits near suspicious lymph nodes or appears to be growing beyond the thyroid’s borders, a biopsy is recommended regardless of its score.
A large cohort study of over 17,500 patients found the actual malignancy rate among all patients with nodules larger than 1 cm was about 1.1% when tiny incidental cancers were excluded. Even among those who underwent needle biopsy, only about 2.4% turned out to be malignant. These numbers are reassuring, but they also explain why accurate risk scoring matters so much: the goal is to catch the small percentage of dangerous nodules without putting everyone else through unnecessary procedures.
Monitoring Benign Nodules
If a biopsy confirms a nodule is benign, the standard approach is periodic ultrasound surveillance rather than treatment. The American Thyroid Association recommends risk-based follow-up: nodules that looked more suspicious on ultrasound (even though the biopsy was benign) get a repeat ultrasound and possibly a second biopsy within 12 months. Nodules with lower-suspicion features can be checked less frequently, often at intervals of one to two years, with the schedule stretching out further if the nodule stays stable over time.
This monitoring phase can feel frustrating, but most benign nodules grow slowly or not at all. The point of follow-up is to catch the rare nodule that changes character or grows significantly, which might warrant another biopsy or a shift in management.
When Biopsy Results Are Unclear
About 15% to 30% of needle biopsies come back as “indeterminate,” meaning the cells don’t look clearly benign or clearly malignant. In these cases, molecular testing can help avoid unnecessary surgery. The two most widely used tests both analyze genetic markers in the biopsy sample to estimate cancer risk.
Both leading molecular tests are very good at detecting cancer when it’s present, with sensitivities of 94% and 96% respectively. Their negative predictive values, the likelihood that a “benign” result is truly benign, are similarly strong at 96% and 93%. Where they fall short is specificity: both correctly identify only about 40% of benign nodules as benign in surgically confirmed cases, meaning a “suspicious” result still leads to surgery that sometimes reveals no cancer. Still, a reassuring molecular result can confidently spare you an operation.
Radiofrequency Ablation for Symptomatic Nodules
Radiofrequency ablation (RFA) has become a mainstream option for benign nodules that cause pressure symptoms, visible neck swelling, or cosmetic concerns. During the procedure, a thin needle-like probe is inserted into the nodule under ultrasound guidance, and heat energy destroys the tissue from the inside. It’s typically done under local anesthesia as an outpatient procedure.
RFA is effective. About 92% of treated nodules shrink by at least 50% within the first year. The nodule doesn’t disappear entirely in most cases, but the reduction is usually enough to relieve symptoms and improve appearance. Over five years, roughly 23% of treated nodules regrow to some degree, and about 12% need a second treatment. This makes RFA a good option if you want to avoid surgery but need meaningful symptom relief.
Ethanol Injection for Fluid-Filled Cysts
Thyroid cysts, nodules that are mostly or entirely filled with fluid, respond well to a simpler approach: ethanol injection. A doctor uses ultrasound to guide a needle into the cyst, drains the fluid, and injects a small amount of alcohol to collapse the cavity. The average volume reduction for cysts is about 65%, and roughly one in four cysts disappears completely. Solid nodules respond less impressively, with an average volume reduction closer to 38%. This makes ethanol injection best suited for predominantly cystic nodules rather than solid ones.
Radioactive Iodine for Overactive Nodules
Some thyroid nodules produce excess thyroid hormone on their own, a condition called a toxic nodule. These “hot” nodules show up brightly on a thyroid scan and can cause hyperthyroidism symptoms like rapid heartbeat, weight loss, and anxiety. Radioactive iodine therapy is a common treatment.
You swallow a capsule or liquid containing radioactive iodine, which concentrates in the overactive nodule and gradually destroys it. Within three months, the nodule typically shrinks by about 35%, reaching up to 45% volume reduction by two years. The primary goal isn’t shrinkage, though. It’s normalizing your thyroid hormone levels. Some people develop an underactive thyroid afterward and need daily thyroid hormone replacement, but this is a manageable, well-understood trade-off.
Thyroid Hormone Suppression Therapy
Taking synthetic thyroid hormone to lower your TSH level (the hormone that stimulates thyroid growth) seems like it should shrink nodules, but the evidence is underwhelming. Most studies show that few nodules actually regress with this approach. Clinical guidelines generally recommend against it for routine use because the side effects of long-term TSH suppression, including bone loss and heart rhythm problems, outweigh the modest benefits.
There are exceptions. Younger patients with growing nodules, people with a history of childhood radiation exposure, or those living in iodine-deficient areas may benefit from a trial of mild suppression. In these cases, the goal is usually to keep TSH in the low-normal range rather than fully suppressed, which reduces the risks.
Surgery for Cancer or Large Nodules
Surgery becomes the treatment when a nodule is confirmed or strongly suspected to be cancerous, when it’s so large that it compresses your airway or esophagus, or when it extends below your collarbone into your chest. The two main options are removing one lobe of the thyroid (lobectomy) or removing the entire gland (total thyroidectomy).
The 2015 American Thyroid Association guidelines shifted the landscape significantly. Previously, almost all thyroid cancers larger than 1 cm were treated with total thyroidectomy. Now, lobectomy is considered a viable option for low-risk, well-differentiated thyroid cancers up to 4 cm, as long as there’s no spread to lymph nodes, no aggressive cell types, and no growth beyond the thyroid capsule. Lobectomy preserves half the gland, which means about half of patients won’t need lifelong thyroid hormone replacement afterward.
Total thyroidectomy is still recommended for larger cancers, aggressive subtypes, cancers that have spread to lymph nodes, or when the cancer appears on both sides of the thyroid. After a total thyroidectomy, you’ll take daily thyroid hormone replacement for life.
What Recovery Looks Like
Most thyroid surgery patients spend one night in the hospital for monitoring. Full recovery takes about two to three weeks, though you should avoid vigorous exercise and heavy lifting for at least the first one to two weeks. The most common complications are temporary changes in voice (from irritation of the nerve that runs near the thyroid) and temporary drops in calcium levels if the parathyroid glands are affected during surgery. Both usually resolve within weeks to months.